Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotypic resistance tests for the management of the HIV-infected patient with non-B viral isolates.

Scandinavian journal of infectious diseases. Supplementum - 1 Jan 2003

Visco-Comandini Ubaldo, Balotta Claudia

Abstract excerpt

Witness for the prosecution: The dominating HIV-1 subtype in Europe and in the USA is the B subtype, but the prevalence of circulating recombinant forms and non-B subtypes (nBS) in Europe has increased. HIV-1 group O strains are spontaneously resistant to non-nucleoside analogue reverse transcriptase inhibitors (NNRTI) and little is known about the antiretroviral (ARV) drug susceptibility of nBS clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to DNA, Viral
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Protease

Share to Microbial Sensitivity Tests

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 15000590

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotypic resistance tests for the management of the HIV-infected patient with non-B viral isolates.PMID 15000590Read ↗

Drug resistance in non-subtype B HIV-1.Semantic proximity Read ↗

Transmitted Drug Resistance in Nonsubtype B HIV-1 InfectionSemantic proximity Read ↗

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.Semantic proximity Read ↗

HIV-1 Genetic Variability and Clinical ImplicationsSemantic proximity Read ↗

Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review.Semantic proximity Read ↗

Emergence of uncommon HIV-1 non-B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013-2015 period in Marseille, Southeastern France.Semantic proximity Read ↗

European recommendations for the clinical use of HIV drug resistance testing: 2011 update.Semantic proximity Read ↗

Resistance-associated mutation prevalence according to subtypes B and non-B of HIV type 1 in antiretroviral-experienced patients in Minas Gerais, Brazil.Semantic proximity Read ↗

Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence.Semantic proximity Read ↗

Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy.Semantic proximity Read ↗

High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba.Semantic proximity Read ↗

HIV-1 non-B subtypes: High transmitted NNRTI-resistance in Spain and impaired genotypic resistance interpretation due to variability.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.